BMS backs Stand Up To Cancer lung research

Share this article:

Bristol-Myers Squibb is kicking in $5 million to support a new lung cancer research “Dream Team.” The money is going toward a new collaboration between the American Cancer Society and the group Stand Up To Cancer.

The BMS contribution covers 20% of the Dream Team's three-year research budget.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Illumina inks deal with J&J, AstraZeneca, Sanofi

The goal is to develop companion diagnostics to match patients with cancer treatments.

Abbott deal highlights inversion inaction

Political furor over the recent spate of tax inversions is having little influence on how the government chooses its partners.

Allergan reported to seek out Salix deal

The Wall Street Journal says the deal would add "another layer of intrigue" to the Allergan-Valeant hostilities.